Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Translational Research : the Journal of Laboratory and Clinical Medicine
|
August 3, 2020
Partnering patients, caregivers, and basic scientists: an engagement model that fosters patient- and family-centered research culture
Dana Ketcher, Anne Bidelman, Liem Q Le, et al.
Nature Immunology
|
November 18, 2008
The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance
Alejandro Villagra, Fengdong Cheng, Hong-Wei Wang, et al.
International Journal of Molecular Sciences
|
January 30, 2021
Constitutively Activated DAP12 Induces Functional Anti-Tumor Activation and Maturation of Human Monocyte-Derived DC
Robert Dalton, Alexandra Calescibetta, Jun Min Zhou, et al.
Plos One
|
April 22, 2026
Correction: Combining lenalidomide with IL-2 family of cytokines enhances activating receptor and perforin/granzyme expression in NK cells
Alexandra Calescibetta, Robert Dalton, Nicole Fortenbery, et al.
Plos One
|
March 12, 2026
Combining lenalidomide with IL-2 family of cytokines enhances activating receptor and perforin/granzyme expression in NK cells
Alexandra Calescibetta, Robert Dalton, Nicole Fortenbery, et al.
Oncogene
|
April 18, 2002
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
Guilian Niu, Kenneth L Wright, Mei Huang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 12, 2022
Immunodepletion of MDSC by AMV564, a novel bivalent, bispecific CD33/CD3 T cell engager, ex vivo in MDS and melanoma
Pingyan Cheng, Xianghong Chen, Robert Dalton, et al.
Cancer Cell
|
June 13, 2023
Retraction Notice to: Coordinated Silencing of MYC-Mediated miR-29 by HDAC3 and EZH2 as a Therapeutic Target of Histone Modification in Aggressive B-Cell Lymphomas
Xinwei Zhang, Xiaohong Zhao, Warren Fiskus, et al.
Cancer Cell
|
October 20, 2012
Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas
Xinwei Zhang, Xiaohong Zhao, Warren Fiskus, et al.
International Journal of Molecular Sciences
|
February 25, 2023
Oxidized Mitochondrial DNA Engages TLR9 to Activate the NLRP3 Inflammasome in Myelodysplastic Syndromes
Grace A Ward, Robert P Dalton, Benjamin S Meyer, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Translational Research : the Journal of Laboratory and Clinical Medicine
|
August 3, 2020
Partnering patients, caregivers, and basic scientists: an engagement model that fosters patient- and family-centered research culture
Dana Ketcher, Anne Bidelman, Liem Q Le, et al.
Nature Immunology
|
November 18, 2008
The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance
Alejandro Villagra, Fengdong Cheng, Hong-Wei Wang, et al.
International Journal of Molecular Sciences
|
January 30, 2021
Constitutively Activated DAP12 Induces Functional Anti-Tumor Activation and Maturation of Human Monocyte-Derived DC
Robert Dalton, Alexandra Calescibetta, Jun Min Zhou, et al.
Plos One
|
April 22, 2026
Correction: Combining lenalidomide with IL-2 family of cytokines enhances activating receptor and perforin/granzyme expression in NK cells
Alexandra Calescibetta, Robert Dalton, Nicole Fortenbery, et al.
Plos One
|
March 12, 2026
Combining lenalidomide with IL-2 family of cytokines enhances activating receptor and perforin/granzyme expression in NK cells
Alexandra Calescibetta, Robert Dalton, Nicole Fortenbery, et al.
Oncogene
|
April 18, 2002
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
Guilian Niu, Kenneth L Wright, Mei Huang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 12, 2022
Immunodepletion of MDSC by AMV564, a novel bivalent, bispecific CD33/CD3 T cell engager, ex vivo in MDS and melanoma
Pingyan Cheng, Xianghong Chen, Robert Dalton, et al.
Cancer Cell
|
June 13, 2023
Retraction Notice to: Coordinated Silencing of MYC-Mediated miR-29 by HDAC3 and EZH2 as a Therapeutic Target of Histone Modification in Aggressive B-Cell Lymphomas
Xinwei Zhang, Xiaohong Zhao, Warren Fiskus, et al.
Cancer Cell
|
October 20, 2012
Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas
Xinwei Zhang, Xiaohong Zhao, Warren Fiskus, et al.
International Journal of Molecular Sciences
|
February 25, 2023
Oxidized Mitochondrial DNA Engages TLR9 to Activate the NLRP3 Inflammasome in Myelodysplastic Syndromes
Grace A Ward, Robert P Dalton, Benjamin S Meyer, et al.
Page
of 5